CPDE9714: Redefining control with next generation glargine

Medcomet

This module discusses the common barriers to the initiation and intensification of insulin therapy, and the efficacy exhibited by next-generation long-acting analogues, like Gla-300 in establishing glycaemic control in patients with diabetes.

This module is based on a CPD symposium delivered by Professor Kamlesh Khunti.

You must be a member to access this content.

To become a member, please register here.

If you're already a member, please sign in to access.